CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-09-09 | RODDY PETER S Chief Financial Officer | Grant or award · Stock Options | +70,000 | $5.83 | $408K | 790,000 |
| 2010-09-09 | SCHOENHARD GRANT Chief Scientific Officer | Grant or award · Common Stock | +70,000 | $5.83 | $408K | 724,000 |
| 2010-09-09 | FRIEDMANN NADAV Chief Operating Officer | Grant or award · Stock Options | +150,000 | $5.83 | $875K | 2,310,000 |
| 2010-09-09 | BARBIER REMI CEO &Chairman of the Board | Grant or award · Stock Options | +300,000 | $5.83 | $1.7M | 3,001,500 |
| 2010-09-07 | BARBIER REMI CEO & Chairman of the Board | Sale | −16,264 | $5.60 | $91K | 5,979,587 |
| 2010-09-03 | BARBIER REMI CEO & Chairman of the Board | Sale | −12,333 | $5.80 | $72K | 5,995,851 |
| 2010-09-02 | BARBIER REMI CEO & Chairman of the Board | Sale | −11,097 | $5.87 | $65K | 6,008,184 |
| 2010-09-01 | BARBIER REMI CEO & Chairman of the Board | Sale | −10,306 | $5.75 | $59K | 6,019,281 |
| 2010-08-09 | BARBIER REMI CEO & Chairman of the Board | Sale | −6,468 | $5.81 | $38K | 6,029,587 |
| 2010-08-06 | BARBIER REMI CEO & Chairman of the Board | Sale | −9,496 | $5.53 | $53K | 6,036,055 |
| 2010-08-05 | BARBIER REMI CEO & Chairman of the Board | Sale | −3,505 | $5.60 | $20K | 6,045,551 |
| 2010-08-04 | BARBIER REMI CEO & Chairman of the Board | Sale | −6,582 | $5.64 | $37K | 6,049,056 |
| 2010-08-03 | BARBIER REMI CEO & Chairman of the Board | Sale | −6,457 | $5.75 | $37K | 6,055,638 |
| 2010-08-02 | BARBIER REMI CEO & Chairman of the Board | Sale | −9,352 | $5.74 | $54K | 6,062,095 |
| 2010-07-16 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise | +1,500 | $4.40 | $7K | 49,687 |
| 2010-07-16 | SCHOENHARD GRANT Chief Scientific Officer | Sale | −1,500 | $5.54 | $8K | 48,157 |
| 2010-07-16 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | +1,500 | $4.40 | $7K | 654,000 |
| 2010-07-07 | BARBIER REMI CEO and Chairman of the Board | Sale | −7,071 | $5.37 | $38K | 6,071,447 |
| 2010-07-06 | BARBIER REMI CEO and Chairman of the Board | Sale | −20,172 | $5.34 | $108K | 6,078,518 |
| 2010-07-02 | BARBIER REMI CEO and Chairman of the Board | Sale | −11,065 | $5.42 | $60K | 6,098,690 |
Page 22 of 25 · 498 trades